192 related articles for article (PubMed ID: 37781912)
1. Association of Tear Cytokine Ratios with Symptoms and Signs of Dry Eye Disease: Biomarker Data from the Dry Eye Assessment and Management Study.
Zhao CS; Chen Y; Ying GS; Asbell PA;
Curr Eye Res; 2024 Jan; 49(1):16-24. PubMed ID: 37781912
[TBL] [Abstract][Full Text] [Related]
2. A latent profile analysis of tear cytokines and their association with severity of dry eye disease in the Dry Eye Assessment and Management (DREAM) study.
Chen Y; Mallem K; Asbell PA; Ying GS
Sci Rep; 2024 Jan; 14(1):526. PubMed ID: 38177232
[TBL] [Abstract][Full Text] [Related]
3. Association of Tear Cytokine Concentrations with Symptoms and Signs of Dry Eye Disease: Baseline Data from the Dry Eye Assessment and Management (DREAM) Study.
Roy NS; Wei Y; Ying GS; Maguire MG; Asbell PA;
Curr Eye Res; 2023 Apr; 48(4):339-347. PubMed ID: 36632643
[TBL] [Abstract][Full Text] [Related]
4. Association Between Depression and Severity of Dry Eye Symptoms, Signs, and Inflammatory Markers in the DREAM Study.
Zhou Y; Murrough J; Yu Y; Roy N; Sayegh R; Asbell P; Maguire MG; Ying GS;
JAMA Ophthalmol; 2022 Apr; 140(4):392-399. PubMed ID: 35266971
[TBL] [Abstract][Full Text] [Related]
5. Association of Dry Eye Symptoms and Signs in Patients with Dry Eye Disease.
Tawfik A; Pistilli M; Maguire MG; Chen Y; Yu Y; Greiner JV; Asbell PA; Ying GS;
Ophthalmic Epidemiol; 2024 Jun; 31(3):274-282. PubMed ID: 37592829
[TBL] [Abstract][Full Text] [Related]
6. Association between systemic medication use and severity of dry eye signs and symptoms in the DRy eye assessment and management (DREAM) study.
Guo M; Diaz GM; Yu Y; Patel CA; Farrar JT; Asbell PA; Ying GS;
Ocul Surf; 2024 Apr; 32():112-119. PubMed ID: 38307463
[TBL] [Abstract][Full Text] [Related]
7. Correlations between tear cytokines, chemokines, and soluble receptors and clinical severity of dry eye disease.
Na KS; Mok JW; Kim JY; Rho CR; Joo CK
Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5443-50. PubMed ID: 22789923
[TBL] [Abstract][Full Text] [Related]
8. Systemic Conditions Associated with Severity of Dry Eye Signs and Symptoms in the Dry Eye Assessment and Management Study.
Yu K; Bunya V; Maguire M; Asbell P; Ying GS;
Ophthalmology; 2021 Oct; 128(10):1384-1392. PubMed ID: 33785415
[TBL] [Abstract][Full Text] [Related]
9. Study design and baseline findings from the progression of ocular findings (PROOF) natural history study of dry eye.
McDonnell PJ; Pflugfelder SC; Stern ME; Hardten DR; Conway T; Villanueva L; Hollander DA
BMC Ophthalmol; 2017 Dec; 17(1):265. PubMed ID: 29284427
[TBL] [Abstract][Full Text] [Related]
10. Inflammation-related molecules in tears of patients with chronic ocular pain and dry eye disease.
Blanco-Vázquez M; Vázquez A; Fernández I; Novo-Diez A; Martínez-Plaza E; García-Vázquez C; González-García MJ; Sobas EM; Calonge M; Enríquez-de-Salamanca A
Exp Eye Res; 2022 Jun; 219():109057. PubMed ID: 35358536
[TBL] [Abstract][Full Text] [Related]
11. Matrix Metalloproteinase 9 Testing in Dry Eye Disease Using a Commercially Available Point-of-Care Immunoassay.
Messmer EM; von Lindenfels V; Garbe A; Kampik A
Ophthalmology; 2016 Nov; 123(11):2300-2308. PubMed ID: 27665213
[TBL] [Abstract][Full Text] [Related]
12. Tear Interferon-Gamma as a Biomarker for Evaporative Dry Eye Disease.
Jackson DC; Zeng W; Wong CY; Mifsud EJ; Williamson NA; Ang CS; Vingrys AJ; Downie LE
Invest Ophthalmol Vis Sci; 2016 Sep; 57(11):4824-4830. PubMed ID: 27654409
[TBL] [Abstract][Full Text] [Related]
13. Age Associations with Dry Eye Clinical Signs and Symptoms in the Dry Eye Assessment and Management (DREAM) Study.
Zhao M; Yu Y; Ying GS; Asbell PA; Bunya VY;
Ophthalmol Sci; 2023 Jun; 3(2):100270. PubMed ID: 36846104
[TBL] [Abstract][Full Text] [Related]
14. The Use of Conjunctival Staining to Measure Ocular Surface Inflammation in Patients With Dry Eye.
Yang S; Lee HJ; Kim DY; Shin S; Barabino S; Chung SH
Cornea; 2019 Jun; 38(6):698-705. PubMed ID: 30844839
[TBL] [Abstract][Full Text] [Related]
15. Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease.
Enríquez-de-Salamanca A; Castellanos E; Stern ME; Fernández I; Carreño E; García-Vázquez C; Herreras JM; Calonge M
Mol Vis; 2010 May; 16():862-73. PubMed ID: 20508732
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of the IL-33/ST2 pathway in dry eye.
Wang S; Zhang H
Mol Vis; 2019; 25():583-592. PubMed ID: 31673224
[TBL] [Abstract][Full Text] [Related]
17. Performance of tear osmolarity compared to previous diagnostic tests for dry eye diseases.
Versura P; Profazio V; Campos EC
Curr Eye Res; 2010 Jul; 35(7):553-64. PubMed ID: 20597641
[TBL] [Abstract][Full Text] [Related]
18. Tear Inflammatory Cytokines Analysis and Clinical Correlations in Diabetes and Nondiabetes With Dry Eye.
Liu R; Ma B; Gao Y; Ma B; Liu Y; Qi H
Am J Ophthalmol; 2019 Apr; 200():10-15. PubMed ID: 30552892
[TBL] [Abstract][Full Text] [Related]
19. Severity, therapeutic, and activity tear biomarkers in dry eye disease: An analysis from a phase III clinical trial.
Pinto-Fraga J; Enríquez-de-Salamanca A; Calonge M; González-García MJ; López-Miguel A; López-de la Rosa A; García-Vázquez C; Calder V; Stern ME; Fernández I
Ocul Surf; 2018 Jul; 16(3):368-376. PubMed ID: 29772277
[TBL] [Abstract][Full Text] [Related]
20. Analysis of Th17-associated cytokines and clinical correlations in patients with dry eye disease.
Liu R; Gao C; Chen H; Li Y; Jin Y; Qi H
PLoS One; 2017; 12(4):e0173301. PubMed ID: 28379971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]